Correction to: Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation

被引:0
|
作者
Emine Tashan
Alptug Karakucuk
Nevin Celebi
机构
[1] Faculty of Pharmacy Gazi University,Department of Pharmaceutical Technology
[2] Zoleant Pharmaceuticals International,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Several typos occurred during the production process and captions were misplaced. The corrected captions for Picture 1, Fig. 6-9 are below.
引用
收藏
相关论文
共 50 条
  • [1] Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation
    Emine Tashan
    Alptug Karakucuk
    Nevin Celebi
    [J]. AAPS PharmSciTech, 21
  • [2] Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation
    Tashan, Emine
    Karakucuk, Alptug
    Celebi, Nevin
    [J]. AAPS PHARMSCITECH, 2020, 21 (03)
  • [3] Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation (vol 21, 115, 2020)
    Tashan, Emine
    Karakucuk, Alptug
    Celebi, Nevin
    [J]. AAPS PHARMSCITECH, 2020, 21 (05)
  • [4] DESIGN AND DEVELOPMENT OF ONDANSETRON ORALLY DISINTEGRATING TABLETS AND ITS OPTIMIZATION USING DESIGN OF EXPERIMENT
    Bhasin, Rakesh Kumar
    Ghosh, Pradip Kumar
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2012, 3 (03): : 840 - 847
  • [5] Development and optimization of lyophilized orally disintegrating tablets using factorial design
    Ahmed, Iman Saad
    Shamma, Rehab Nabil
    Shoukri, Ragia Ali
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2013, 18 (04) : 935 - 943
  • [6] Optimization and In vitro Evaluation of Famotidine Loaded Effervescent Orally Disintegrating Tablets Using Central Composite Design
    Kumar, Ramesh
    Verma, Ravinder
    Kaushik, Ritu
    Kaushik, Prerna
    Pandey, Parijat
    Purohit, Deepika
    Mittal, Vineet
    Kaushik, Deepak
    [J]. CURRENT DRUG THERAPY, 2021, 16 (04) : 336 - 344
  • [7] Development and optimization of fluoxetine orally disintegrating tablets using Box-Behnken design
    Ali, Bahaa E.
    Rabba, Abdullah K.
    Fayed, Mohamed H.
    El-Say, Khalid M.
    Anwer, Mohammad Khalid
    Ansari, Mohammad Javed
    Al-Shdefat, Ramadan
    Gabr, Gamal A.
    [J]. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2016, 15 (04) : 667 - 677
  • [8] Development and evaluation of ofloxacin orally disintegrating tablets
    Mohite, Badrinath Pralhadrao
    Chafle, Sandip Annaji
    Somasundaram, Jayaprakash
    Avari, Jasmine Gev
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 48 (02) : 217 - 225
  • [9] Quality by Design Approach for Design, Development and Optimization of Orally Disintegrating Tablets of Montelukast Sodium
    Sholapur, Hasan Pasha Nazeer Ahmed
    Dasankoppa, Fatima Sanjeri
    Channabasavaraja, Mudlapur
    Sagare, Revati Dharampal
    Abbas, Zaheer
    Swamy, Nanjangud Gangadhariah Nanjunda
    Sai, Lakshmi Swapna
    Kshatriya, Kamaladevi
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2021, 11 (03) : 288 - 295
  • [10] Development of ivermectin orally disintegrating tablets using factorial design: In-vitro evaluation and in vivo absorption pattern in rats
    Juan, Candela
    Rodriguez, Daiana
    Ceballos, Laura
    Lanusse, Carlos
    Gallo, Loreana
    Vidal, Noelia Gonzalez
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 87